⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GUTS News
Fractyl Health, Inc. Common Stock
Fractyl Health to Participate in the 8th Annual Evercore Healthcare Conference
globenewswire.com
GUTS
Fractyl Health Reports Third Quarter 2025 Results; Revita® Clinical Momentum Builds Toward 2026 Pivotal Readout and PMA Filing, Cash Runway Extended into Early 2027
globenewswire.com
GUTS
Fractyl Health to Report Third Quarter 2025 Financial Results and Provide Business Updates on November 12, 2025
globenewswire.com
GUTS
Fractyl Health Announces Potent Preclinical Results from RJVA-002, a Dual GIP/GLP-1 Gene Therapy Candidate for Obesity
globenewswire.com
GUTS
Fractyl Health Announces Pricing of $60 Million Underwritten Offering of Common Stock
globenewswire.com
GUTS
Fractyl Health Announces Groundbreaking Data from REMAIN-1 Midpoint Cohort Showing Revita® Maintained Weight Loss After GLP-1 Discontinuation
globenewswire.com
GUTS